Skip to content

An Observational Study to Evaluate the Effect of Siddha Formulations in reducing Chemoradiotherapy-Induced side effects in Cancer Patients

A Prospective Comparative Observational Study to Evaluate the Effectiveness of Siddha Formulations in Alleviating Chemoradiotherapy-Induced Adverse Effects(Toxicity) in Cancer Patients Attending the OPD of Ayothidoss Pandithar Hospital, National Institute of Siddha - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/080249
Enrollment
80
Registered
2025-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C800- Disseminated malignant neoplasm, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of carcinoma under Radiotherapy or Chemotherapy or Both, and post radiation participants with symptoms. Those complaining of one or more Adverse effects Such as Nausea, vomiting, Mucositis, Fatigue, Xerostomia, Tastelessness, Skin reaction, Alopecia. Patients who are willing to give informed consent.

Exclusion criteria

Exclusion criteria: Pregnant Or lactating women Patients not willing to give informed consent.

Design outcomes

Primary

MeasureTime frame
The effectiveness of the therapy of Group A and Group B will be compared before and after treatment by comparing the reduction in the adverse effects of the chemo- radiotherapy , using grades.Timepoint: Study commencement and conduct of the study - 15 Months Outcome Assessment - 3 Months

Secondary

MeasureTime frame
Safety to be assessed by LFT , RFT and haemotological parameters Such as Haemoglobin.Timepoint: Study commencement and conduct of the study - 15 Months Outcome Assessment - 3 Months

Countries

India

Contacts

Public ContactDr S Murugesan

National Institute of Siddha

ss.drss@gmail.com9841108269

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026